Highlands Hospital has been selected as one of a handful of organizations nationally that will be participating in the Clinical Breast Care Project of the Department of Defense based at Walter Reed National Military Medical Center at Bethesda. The goal of this work is to identify markers that may enable early breast cancer detection, monitoring, and prediction through less invasive procedures.
As a member of this select group of organizations which includes Anne Arundel Medical Center in Annapolis, Maryland, Walter Reed, and the Chan Soon Shiong Institute for Molecular Medicine at Windber, Highlands Hospital will be participating in breast cancer risk studies looking at diagnostics, management and molecular mechanisms associated with the onset, progression, and severity of breast cancer.
Participants in this effort will be providing anonymous blood samples that will correlate with patient risk factors. Since this program is based on prevention, screening, diagnosis, treatment, and management of breast disease, it provides the necessary framework for an integrated approach to treatment which will positively impact future management of breast cancer. Participants in this program are literally “Paying it forward” as their contribution of small samples of blood may lead to cures and early detection of breast cancer for future generations. Participation in this program will also help to keep Highlands Hospital on the leading edge of breast care treatments.